Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by Staghorn69on Nov 17, 2017 4:01pm
169 Views
Post# 26986611

RE:RE:RE:RE:RE:RE:RE:RE:RE:Plasminogen & PBI-4050 Market Size worth US$ 150+ Billion

RE:RE:RE:RE:RE:RE:RE:RE:RE:Plasminogen & PBI-4050 Market Size worth US$ 150+ Billion
Biofinder wrote:
Staghorn69 wrote:
Biofinder wrote:
joe9999 wrote: As I said ... ONE STEP at a time ...

Even if you cut and paste "hyperbolic affirmations" ... MADE BY analysts ...  it doesn't change their "rosy picture" characteristics !! 

Just an example ...  I'm not sure at all that the STUDY on CYSTIC FIBROSIS is "really alive" !  And I personnaly ask Fred Dumais about that 2 weeks ago ...  hard to find "patients" for this study ... and PLI doesn't talk anymore about that ...  Do they still walk that road ???  I am not sure ...  I think you can SKIP this "market" in your "total" for now ....  Minus 13 billions ...

PS:  I have a very good knowledge of the company, trust me ... since I'm on the boat ... for about 16 years now ...  I'm pretty confident about its future ... but I still find important to keep away "rosy glasses" ...
 


sounds good. you wear your glasses and I’ll wear mine, thank you.

as for me, I like to think in terms of potential since we’re referring to future events.

 


Well for a company with a $150 Billion USD market 100% in their grasp as you put it, there sure are a lot of sellers lining up to dump shares at this price... Explain that chasm in value?? Is the market just THAT wrong?? I HIGHLY doubt it.


Dear shortie: in case you hadn’t noticed, this is the year 2017, not 2020. I’ve said it more than once that “only shorts and day traders care about the pps at this time”, my horizon has always been the year 2020 and beyond... and I do wish that you could read and comprehend English, I said that Prometic will own 100% (less % for partnerships) of PLASMINOGEN not for PBI-4050... you shorts are such morons...



Key trend in any paid pumpers handbook is to immediately call out anyone who challenges the PUMP as both dumb, and short.... Of which I'm neither. Bepando took that stance when I called out the briliance of the "China Deal" and look where that call of mine stands now... But I wish I did go short a LONG time ago because they are the only ones making any money on this stock.... That is, until 2020 I guess. LOL. You're on fire today.
Bullboard Posts